Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (441-450 of 941) with videos related to

Pageof 95
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|September 10, 2014
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitroSteven Pham, Subrata Deb, Dong Sheng Ming, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonistsRobert J Gleave, Daryl S Walter, Paul J Beswick, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 11, 2011
Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution seriesAnthony J Koupparis, Jeremy P Grummet, Antonio Hurtado-Coll, et al.
International Journal of Cancer|August 19, 2014
Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancerThomas Cordonnier, Jennifer L Bishop, Masaki Shiota, et al.
The Journal of Urology|May 16, 2012
Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancerEvan Y Yu, Kurt Miller, Joel Nelson, et al.
Chemistry and Physics of Lipids|March 24, 2004
The diazo ketone approach to the isoprostanesDouglass F Taber, R Scott Hoerrner, R Jason Herr, et al.
The Journal of Biological Chemistry|July 11, 1997
Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaPN Sato, M D Sadar, N Bruchovsky, et al.
Journal of Chemical Information and Modeling|December 8, 2015
The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR-Ligand InteractionsAlexander Heifetz, Ewa I Chudyk, Laura Gleave, et al.
Clinical Genitourinary Cancer|January 23, 2016
Moving Toward Personalized Care: Liquid Biopsy Predicts Response to Cisplatin in an Unusual Case of BRCA2-Null Neuroendocrine Prostate CancerEdmund C P Chedgy, Matti Annala, Kevin Beja, et al.
BMJ Open|August 13, 2021
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study designStephen J Freedland, Ugo De Giorgi, Martin Gleave, et al.
Pageof 95

Showing results (441-450 of 941) with videos related to

Sort By:
Pageof 95
The Journal of Steroid Biochemistry and Molecular Biology|September 10, 2014
Next-generation steroidogenesis inhibitors, dutasteride and abiraterone, attenuate but still do not eliminate androgen biosynthesis in 22RV1 cells in vitroSteven Pham, Subrata Deb, Dong Sheng Ming, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2010
Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonistsRobert J Gleave, Daryl S Walter, Paul J Beswick, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 11, 2011
Radical prostatectomy for high-risk clinically localized prostate cancer: a prospective single institution seriesAnthony J Koupparis, Jeremy P Grummet, Antonio Hurtado-Coll, et al.
International Journal of Cancer|August 19, 2014
Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancerThomas Cordonnier, Jennifer L Bishop, Masaki Shiota, et al.
The Journal of Urology|May 16, 2012
Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancerEvan Y Yu, Kurt Miller, Joel Nelson, et al.
Chemistry and Physics of Lipids|March 24, 2004
The diazo ketone approach to the isoprostanesDouglass F Taber, R Scott Hoerrner, R Jason Herr, et al.
The Journal of Biological Chemistry|July 11, 1997
Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaPN Sato, M D Sadar, N Bruchovsky, et al.
Journal of Chemical Information and Modeling|December 8, 2015
The Fragment Molecular Orbital Method Reveals New Insight into the Chemical Nature of GPCR-Ligand InteractionsAlexander Heifetz, Ewa I Chudyk, Laura Gleave, et al.
Clinical Genitourinary Cancer|January 23, 2016
Moving Toward Personalized Care: Liquid Biopsy Predicts Response to Cisplatin in an Unusual Case of BRCA2-Null Neuroendocrine Prostate CancerEdmund C P Chedgy, Matti Annala, Kevin Beja, et al.
BMJ Open|August 13, 2021
A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study designStephen J Freedland, Ugo De Giorgi, Martin Gleave, et al.
Pageof 95